◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY
Home › All stocks › ARWR › Net Income

Arrowhead Pharmaceuticals, Inc. (ARWR) Net Income 2021–2025

DATA UPDATED 2026-07-26

Arrowhead Pharmaceuticals, Inc. annual net income for fiscal 2025 was -$2 million, an increase of 99.7% from -$600 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

ARWR Annual Net Income

Net Income (annual)2025-09-302024-09-302023-09-302022-09-302021-09-30
Net Income($2M)($600M)($205M)($176M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ARWR Quarterly Net Income

Net Income (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Net Income($133M)$31M($24M)($175M)$370M—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More ARWR metrics: Revenue · Operating Income · EPS · Free Cash Flow

All ARWR financial statements → Interactive ARWR charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.